OBJECTIVE: To develop a novel polytrauma model that better recapitulates the immunologic response of the severely injured patient by combining long-bone fracture, muscle tissue damage, and cecectomy with hemorrhagic shock, resulting in an equivalent Injury Severity Score of greater than 15. We compared this new polytrauma/shock model to historically used murine trauma-hemorrhage models. DESIGN: Pre-clinical controlled in vivo laboratory study. SETTING: Laboratory of Inflammation Biology and Surgical Science. SUBJECTS: Six- to 10-week-old C57BL/6 (B6) mice. INTERVENTIONS: Mice underwent 90 minutes of shock (mean arterial pressure 30 mm Hg) and resuscitation via femoral artery cannulation followed by laparotomy (trauma-hemorrhage), hemorrhage with laparotomy and femur fracture, or laparotomy with cecetomy and femur fracture with muscle tissue damage (polytrauma). Mice were euthanized at 2 hours, 1 day, and 3 days postinjury. MEASUREMENTS AND MAIN RESULTS: The spleen, bone marrow, blood, and serum were collected from mice for analysis at the above time points. None of the models were lethal. Mice undergoing polytrauma exhibited a more robust inflammatory response with significant elevations in cytokine/chemokine concentrations when compared with traditional models. Polytrauma was the only model to induce neutrophilia (Ly6G (+)CD11b(+) cells) on days 1 and 3 (p<0.05). Polytrauma, as compared to trauma-hemorrhage and hemorrhage with laparotomy and femur fracture, induced a loss of circulating CD4(+) T cell with simultaneous increased cell activation (CD69(+) and CD25(+)), similar to human trauma. There was a prolonged loss of major histocompatibility complex class II expression on monocytes in the polytrauma model (p<0.05). Results were confirmed by genome-wide expression analysis that revealed a greater magnitude and duration of blood leukocyte gene expression changes in the polytrauma model than the trauma-hemorrhage and sham models. CONCLUSIONS: This novel polytrauma model better replicates the human leukocyte, cytokine, and overall inflammatory response following injury and hemorrhagic shock.
OBJECTIVE: To develop a novel polytrauma model that better recapitulates the immunologic response of the severely injured patient by combining long-bone fracture, muscle tissue damage, and cecectomy with hemorrhagic shock, resulting in an equivalent Injury Severity Score of greater than 15. We compared this new polytrauma/shock model to historically used murinetrauma-hemorrhage models. DESIGN: Pre-clinical controlled in vivo laboratory study. SETTING: Laboratory of Inflammation Biology and Surgical Science. SUBJECTS: Six- to 10-week-old C57BL/6 (B6) mice. INTERVENTIONS:Mice underwent 90 minutes of shock (mean arterial pressure 30 mm Hg) and resuscitation via femoral artery cannulation followed by laparotomy (trauma-hemorrhage), hemorrhage with laparotomy and femur fracture, or laparotomy with cecetomy and femur fracture with muscle tissue damage (polytrauma). Mice were euthanized at 2 hours, 1 day, and 3 days postinjury. MEASUREMENTS AND MAIN RESULTS: The spleen, bone marrow, blood, and serum were collected from mice for analysis at the above time points. None of the models were lethal. Mice undergoing polytrauma exhibited a more robust inflammatory response with significant elevations in cytokine/chemokine concentrations when compared with traditional models. Polytrauma was the only model to induce neutrophilia (Ly6G (+)CD11b(+) cells) on days 1 and 3 (p<0.05). Polytrauma, as compared to trauma-hemorrhage and hemorrhage with laparotomy and femur fracture, induced a loss of circulating CD4(+) T cell with simultaneous increased cell activation (CD69(+) and CD25(+)), similar to humantrauma. There was a prolonged loss of major histocompatibility complex class II expression on monocytes in the polytrauma model (p<0.05). Results were confirmed by genome-wide expression analysis that revealed a greater magnitude and duration of blood leukocyte gene expression changes in the polytrauma model than the trauma-hemorrhage and sham models. CONCLUSIONS: This novel polytrauma model better replicates the human leukocyte, cytokine, and overall inflammatory response following injury and hemorrhagic shock.
Authors: Richard S Hotchkiss; Kevin W Tinsley; Paul E Swanson; Mitchell H Grayson; Dale F Osborne; Tracey H Wagner; J Perren Cobb; Craig Coopersmith; Irene E Karl Journal: J Immunol Date: 2002-03-01 Impact factor: 5.422
Authors: D S Walsh; P Siritongtaworn; K Pattanapanyasat; P Thavichaigarn; P Kongcharoen; N Jiarakul; P Tongtawe; K Yongvanitchit; C Komoltri; C Dheeradhada; F C Pearce; W P Wiesmann; H K Webster Journal: Br J Surg Date: 2000-02 Impact factor: 6.939
Authors: M W Knöferl; D Jarrar; M K Angele; A Ayala; M G Schwacha; K I Bland; I H Chaudry Journal: Am J Physiol Cell Physiol Date: 2001-10 Impact factor: 4.249
Authors: T Menges; J Engel; I Welters; R M Wagner; S Little; R Ruwoldt; M Wollbrueck; G Hempelmann Journal: Crit Care Med Date: 1999-04 Impact factor: 7.598
Authors: Shih-Ching Kang; Takeshi Matsutani; Mashkoor A Choudhry; Martin G Schwacha; Loring W Rue; Kirby I Bland; Irshad H Chaudry Journal: Cytokine Date: 2004-06-07 Impact factor: 3.861
Authors: Lori F Gentile; Dina C Nacionales; M Cecilia Lopez; Erin Vanzant; Angela Cuenca; Alex G Cuenca; Ricardo Ungaro; Tezcan Ozrazgat Baslanti; Bruce A McKinley; Azra Bihorac; Joseph Cuschieri; Ronald V Maier; Frederick A Moore; Christiaan Leeuwenburgh; Henry V Baker; Lyle L Moldawer; Philip A Efron Journal: Crit Care Med Date: 2014-06 Impact factor: 7.598
Authors: Juan C Mira; Benjamin E Szpila; Dina C Nacionales; Maria-Cecilia Lopez; Lori F Gentile; Brittany J Mathias; Erin L Vanzant; Ricardo Ungaro; David Holden; Martin D Rosenthal; Jaimar Rincon; Patrick T Verdugo; Shawn D Larson; Frederick A Moore; Scott C Brakenridge; Alicia M Mohr; Henry V Baker; Lyle L Moldawer; Philip A Efron Journal: Physiol Genomics Date: 2015-11-17 Impact factor: 3.107
Authors: Dina C Nacionales; Benjamin Szpila; Ricardo Ungaro; M Cecilia Lopez; Jianyi Zhang; Lori F Gentile; Angela L Cuenca; Erin Vanzant; Brittany Mathias; Jeevan Jyot; Donevan Westerveld; Azra Bihorac; Anna Joseph; Alicia Mohr; Lizette V Duckworth; Frederick A Moore; Henry V Baker; Christiaan Leeuwenburgh; Lyle L Moldawer; Scott Brakenridge; Philip A Efron Journal: J Immunol Date: 2015-08-05 Impact factor: 5.422
Authors: Lori F Gentile; Alex G Cuenca; Erin L Vanzant; Philip A Efron; Bruce McKinley; Frederick Moore; Lyle L Moldawer Journal: Methods Date: 2013-05-11 Impact factor: 3.608
Authors: MengQi Zhang; Joshua Montroy; Rahul Sharma; Dean A Fergusson; Asher A Mendelson; Kimberly F Macala; Stephane L Bourque; Jared M Schlechte; Mikaela K Eng; Braedon McDonald; Sean E Gill; Kirsten M Fiest; Patricia C Liaw; Alison Fox-Robichaud; Manoj M Lalu Journal: Crit Care Explor Date: 2021-06-14